Beilstein J. Org. Chem. 2013, 9, 236–245.
2958, 1730, 1434, 1219, 1072, 938, 722 cm−1; 1H NMR (td, J = 13.7, 4.2 Hz, 1H), 1.91 (dt, J = 12.2, 4.4 Hz, 1H),
(400 MHz, CDCl3) δ 6.34 (t, J = 2.7 Hz, 1H), 4.42 (d(AB 1.50–1.20 (m, 6H), 0.88 (t, J = 7.0 Hz, 3H); 13C NMR
system), J = 9.1 Hz, 1H), 4.40 (d br, J = 2.9 Hz, 2H), 3.84 (100 MHz, CDCl3) δ 173.3, 146.7, 98.6, 78.3, 73.9, 58.2, 52.7,
(d(AB system), J = 9.1 Hz, 1H), 3.74 (s, 3H), 1.90 (m, 1H), 32.5, 32.4, 24.1, 22.7, 14.3; HRMS–ESI (m/z): [M + Na]+ calcd
1.68 (m, 1H), 1.24 (m, 2H), 0.91 (t, J = 7.3 Hz, 3H); 13C NMR for C12H19O3BrNa: 313.0410; found: 313.0413.
(100 MHz, CDCl3) δ 172.3, 146.6, 100.4, 75.7, 72.8, 58.5, 52.6,
39.5, 18.8, 14.2; HRMS–ESI (m/z): [M + Na]+ calcd for (E)-Methyl 4-(bromomethylene)-3-ethyltetrahydrofuran-3-
C10H15O3BrNa: 285.00968; found: 285.00990.
carboxylate ((E)-4ac) (Table 3, entry 1): Under argon, to a
stirred solution of β-(propargyloxy)enoate 3a (46 mg,
(E)-Methyl 4-(bromomethylene)-3-propyltetrahydrofuran- 0.2 mmol) in CH2Cl2 (1 mL) at 0 °C was added Me2Zn (1 mL,
3-carboxylate ((E)-4aa): Prepared according to general proce- 1.0 M in heptane, 1.0 mmol). Air (20 mL) was slowly intro-
dure 2 from enoate 3a (47 mg, 0.2 mmol) and Et2Zn (0.6 mL, duced over 1 h into the solution via a syringe pump by using a
1.0 M in hexanes, 0.6 mmol). The title compound ((E)-4aa) was syringe fitted with a CaCl2 guard. The reaction mixture was
isolated pure (47 mg, 89%) as a colorless oil and did not require then stirred at 0 °C for 1 h. CH2Cl2 (5 mL) was then added, and
further purification. IR (neat): 2960, 2873, 1769, 1730, 1433, the reaction was hydrolyzed with an aqueous solution of HCl
1217, 1122, 1074, 968, 938, 742 cm−1; 1H NMR (400 MHz, (1 M, 5 mL). The layers were separated, the aqueous one being
CDCl3) δ 6.15 (t, J = 1.9 Hz, 1H), 4.39 (dd(ABX system), J = extracted with CH2Cl2 (3 × 10 mL). The combined organic
12.7, 1.9 Hz, 1H), 4.32 (dd(ABX system), J = 12.7, 1.8 Hz, layers were washed with brine, dried over MgSO4 and concen-
1H), 4.12 (d(AB system), J = 8.9 Hz, 1H), 3.97 (d(AB system), trated under reduced pressure. Purification by flash chromatog-
J = 8.9 Hz, 1H), 3.74 (s, 3H), 2.13 (td, J = 13.5, 4.6 Hz, 1H), raphy on silica gel (pentane/ether 80:20) afforded the title com-
1.90 (dt, J = 12.5, 4.4 Hz, 1H), 1.50–1.30 (m, 1H), 1.30–1.25 pound ((E)-4ac) (38 mg, 77%) as a colorless oil. IR (neat):
(m, 1H), 0.95 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) 2953, 1767, 1731, 1638, 1229, 1138, 1034, 936, 786 cm−1;
δ 173.3, 146.7, 98.5, 78.3, 73.8, 58.3, 52.7, 34.7, 17.9, 14.8; 1H NMR (400 MHz, CDCl3) δ 6.17 (t, J = 1.9 Hz, 1H), 4.41
HRMS–ESI (m/z): [M + Na]+ calcd for C10H15O3BrNa: (dd(ABX system), J = 12.7, 1.9 Hz, 1H), 4.33 (dd(ABX
285.0097; found: 285.0091.
system), J = 12.7, 1.9 Hz, 1H), 4.13 (d(AB system), J = 8.9 Hz,
1H), 3.98 (d(AB system), J = 8.9 Hz, 1H), 3.75 (s, 3H), 2.21
(Z)-Methyl 4-(iodomethylene)-3-pentyltetrahydrofuran-3- (m, 1H), 2.00 (m, 1H), 0.96 (t, J = 7.5 Hz, 3H); 13C NMR
carboxylate ((Z)-4bb): Prepared according to general proce- (100 MHz, CDCl3) δ 173.2, 146.4, 98.5, 77.9, 73.8, 58.5, 52.6,
dure 1 from enoate 3b (40 mg, 0.14 mmol) and Bu2Zn 25.2, 8.9; HRMS–ESI (m/z): [M + Na]+ calcd for
(0.42 mL, ~1 N in heptane, 0.42 mmol). Purification by flash C9H13O3BrNa: 270.99403; found: 270.99477.
chromatography with pentane/ether (80:20) as eluent gave the
title compound ((Z)-4bb) (28 mg, 58%) as a colorless oil. IR (E)-Methyl 4-(bromomethylene)-3-isobutyltetrahydrofuran-
(neat): 2951, 2925, 2856, 1731, 1434, 1230, 1073, 939, 3-carboxylate ((E)-4ad) (Table 3, entry 4): Under argon, to a
730 cm−1. 1H NMR (400 MHz, CDCl3) δ 6.36 (t, J = 2.6 Hz, stirred solution of β-(propargyloxy)enoate 3a (47 mg,
1H), 4.49 (d(AB system), J = 9.1 Hz, 1H), 4.31 (d br, 0.2 mmol) and iPrI (0.2 mL, 2.0 mmol) in CH2Cl2 (1 mL) at
J = 2.6 Hz, 2H), 3.90 (d(AB system), J = 9.1 Hz, 1H), 3.74 (s, 0 °C was added Me2Zn (0.6 mL, 1.0 M in heptane, 0.6 mmol).
3H), 1.90 (m, 1H), 1.66 (m, 1H), 1.40–1.20 (m, 6H), 0.91 (t, J = Air (20 mL) was slowly introduced over 1 h into the solution
6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 172.3, 152.4, 76.5, via a syringe pump by using a syringe fitted with a CaCl2 guard.
76.2, 71.3, 59.7, 52.7, 37.3, 32.0, 25.1, 22.5, 14.1.
The reaction mixture was then stirred at 0 °C for 1 h. CH2Cl2
(5 mL) was then added and the reaction was hydrolyzed with an
(E)-Methyl 4-(bromomethylene)-3-pentyltetrahydrofuran-3- aqueous solution of HCl (1 M, 5 mL). The layers were sep-
carboxylate ((E)-4ab): Prepared according to general proce- arated, the aqueous one being extracted with CH2Cl2 (3 ×
dure 2 from enoate 3a (47 mg, 0.2 mmol) and Bu2Zn (0.6 mL, 10 mL). The combined organic layers were washed with brine,
~1 N in heptane, 0.6 mmol). The title compound ((E)-4ab) was dried over MgSO4 and concentrated under reduced pressure.
isolated pure (55 mg, 93%) as a colorless oil and did not require Purification by flash chromatography on silica gel (pentane/
further purification. IR (neat): 2955, 2927, 2856, 1771, 1733, ether 50:50) afforded the title compound ((E)-4ad) (36 mg,
1433, 1260, 1230, 1217, 1122, 1074, 936, 910, 731 cm−1; 65%) as a colorless oil. IR (neat): 2953, 2870, 1732, 1640,
1H NMR (400 MHz, CDCl3) δ 6.15 (t, J = 1.9 Hz, 1H), 4.39 1230, 1126, 1073, 937, 695 cm−1; 1H NMR (400 MHz, CDCl3)
(dd(ABX system), J = 12.7, 2.0 Hz, 1H), 4.32 (dd(ABX δ 6.15 (t, J = 1.9 Hz, 1H), 4.40 (d, J = 1.9 Hz, 2H), 4.15 (d(AB
system), J = 12.7, 1.8 Hz, 1H), 4.12 (d(AB system), J = 8.9 Hz, system), J = 8.9 Hz, 1H), 4.02 (d(AB system), J = 8.9 Hz, 1H),
1H), 3.97 (d(AB system), J = 8.9 Hz, 1H), 3.74 (s, 3H), 2.15 3.74 (s, 3H), 2.05 (m, 2H), 1.77 (m, 1H), 0.96 (d, J = 8.4 Hz,
243